Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Molecular classification of cutaneous malignant melanoma by gene expression profiling.

Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, Hendrix M, Radmacher M, Simon R, Yakhini Z, Ben-Dor A, Sampas N, Dougherty E, Wang E, Marincola F, Gooden C, Lueders J, Glatfelter A, Pollock P, Carpten J, Gillanders E, Leja D, Dietrich K, Beaudry C, Berens M, Alberts D, Sondak V.

Nature. 2000 Aug 3;406(6795):536-40.

2.

Gene expression profiling of primary cutaneous melanoma and clinical outcome.

Winnepenninckx V, Lazar V, Michiels S, Dessen P, Stas M, Alonso SR, Avril MF, Ortiz Romero PL, Robert T, Balacescu O, Eggermont AM, Lenoir G, Sarasin A, Tursz T, van den Oord JJ, Spatz A; Melanoma Group of the European Organization for Research and Treatment of Cancer..

J Natl Cancer Inst. 2006 Apr 5;98(7):472-82.

PMID:
16595783
3.

Gene expression profiling of primary cutaneous melanoma.

Winnepenninckx V, Van den Oord JJ.

Verh K Acad Geneeskd Belg. 2007;69(1):23-45. Review.

PMID:
17427873
4.

Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities.

Tschentscher F, Hüsing J, Hölter T, Kruse E, Dresen IG, Jöckel KH, Anastassiou G, Schilling H, Bornfeld N, Horsthemke B, Lohmann DR, Zeschnigk M.

Cancer Res. 2003 May 15;63(10):2578-84.

5.

Micro-RNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling.

Worley LA, Long MD, Onken MD, Harbour JW.

Melanoma Res. 2008 Jun;18(3):184-90. doi: 10.1097/CMR.0b013e3282feeac6.

PMID:
18477892
6.

A metastasis modifier locus on human chromosome 8p in uveal melanoma identified by integrative genomic analysis.

Onken MD, Worley LA, Harbour JW.

Clin Cancer Res. 2008 Jun 15;14(12):3737-45. doi: 10.1158/1078-0432.CCR-07-5144.

7.

Molecular classification of melanomas and nevi using gene expression microarray signatures and formalin-fixed and paraffin-embedded tissue.

Koh SS, Opel ML, Wei JP, Yau K, Shah R, Gorre ME, Whitman E, Shitabata PK, Tao Y, Cochran AJ, Abrishami P, Binder SW.

Mod Pathol. 2009 Apr;22(4):538-46. doi: 10.1038/modpathol.2009.8. Epub 2009 Mar 6.

8.

PUMA expression is significantly reduced in human cutaneous melanomas.

Karst AM, Dai DL, Martinka M, Li G.

Oncogene. 2005 Feb 3;24(6):1111-6.

PMID:
15690057
9.

Molecular classification of melanoma using real-time quantitative reverse transcriptase-polymerase chain reaction.

Lewis TB, Robison JE, Bastien R, Milash B, Boucher K, Samlowski WE, Leachman SA, Dirk Noyes R, Wittwer CT, Perreard L, Bernard PS.

Cancer. 2005 Oct 15;104(8):1678-86.

10.

Increased p21-activated kinase-1 expression is associated with invasive potential in uveal melanoma.

Pavey S, Zuidervaart W, van Nieuwpoort F, Packer L, Jager M, Gruis N, Hayward N.

Melanoma Res. 2006 Aug;16(4):285-96.

PMID:
16845324
11.

Differential expression of thrombospondin 2 in primary and metastatic malignant melanoma.

Kunz M, Koczan D, Ibrahim SM, Gillitzer R, Gross G, Thiesen HJ.

Acta Derm Venereol. 2002;82(3):163-9.

PMID:
12353704
12.

Classification of cutaneous malignant melanoma: a reassessment of histopathologic criteria for the distinction of different types.

Weyers W, Euler M, Diaz-Cascajo C, Schill WB, Bonczkowitz M.

Cancer. 1999 Jul 15;86(2):288-99.

PMID:
10421265
13.

Expression of nm23-H1 in uveal melanoma.

Bakalian S, Marshall JC, Faingold D, Logan P, Antecka E, Burnier MN Jr.

Melanoma Res. 2007 Oct;17(5):284-90.

PMID:
17885583
14.

Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi.

Smith JH, Padnick-Silver L, Newlin A, Rhodes K, Rubinstein WS.

Ophthalmology. 2007 Apr;114(4):774-9. Epub 2007 Jan 3.

PMID:
17207529
15.

BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs.

Wong CW, Fan YS, Chan TL, Chan AS, Ho LC, Ma TK, Yuen ST, Leung SY; Cancer Genome Project..

J Clin Pathol. 2005 Jun;58(6):640-4. Review.

16.

Significance of gene expression analysis in uveal melanoma in comparison to standard risk factors for risk assessment of subsequent metastases.

Petrausch U, Martus P, Tönnies H, Bechrakis NE, Lenze D, Wansel S, Hummel M, Bornfeld N, Thiel E, Foerster MH, Keilholz U.

Eye (Lond). 2008 Aug;22(8):997-1007. Epub 2007 Mar 23.

PMID:
17384575
17.

Prognostic testing in uveal melanoma by transcriptomic profiling of fine needle biopsy specimens.

Onken MD, Worley LA, Dávila RM, Char DH, Harbour JW.

J Mol Diagn. 2006 Nov;8(5):567-73.

18.

Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma.

Scala S, Ottaiano A, Ascierto PA, Cavalli M, Simeone E, Giuliano P, Napolitano M, Franco R, Botti G, Castello G.

Clin Cancer Res. 2005 Mar 1;11(5):1835-41.

19.

Uveal and cutaneous melanoma: shared expression characteristics of melanoma-associated antigens.

van Dinten LC, Pul N, van Nieuwpoort AF, Out CJ, Jager MJ, van den Elsen PJ.

Invest Ophthalmol Vis Sci. 2005 Jan;46(1):24-30.

PMID:
15623750
20.

Clinicopathologic features and behavior of cutaneous eyelid melanoma.

Vaziri M, Buffam FV, Martinka M, Oryschak A, Dhaliwal H, White VA.

Ophthalmology. 2002 May;109(5):901-8.

PMID:
11986095

Supplemental Content

Support Center